{"id":121000,"date":"2021-07-28T08:20:09","date_gmt":"2021-07-28T08:20:09","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=121000"},"modified":"2023-01-15T10:31:19","modified_gmt":"2023-01-15T10:31:19","slug":"thrombolytic-therapy","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/","title":{"rendered":"Thrombolytic therapy"},"content":{"rendered":"

Administration of a pharmacological agent with the intention of causing thrombolysis of an abnormal blood clot, such as in the coronary (myocardial infarction) or pulmonary (pulmonary embolism) arteries. Available agents include streptokinase, urokinase, tissue plasminogen activator, and APSAC. These preparations may be given either intravenously or directly into the blocked artery (intra-arterial).<\/p>\n

\n

The use of drugs that degrade blood clots to treat acute myocardial infarction, pulmonary embolism, or stroke.<\/p>\n

\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Administration of a pharmacological agent with the intention of causing thrombolysis of an abnormal blood clot, such as in the coronary (myocardial infarction) or pulmonary (pulmonary embolism) arteries. Available agents include streptokinase, urokinase, tissue plasminogen activator, and APSAC. These preparations may be given either intravenously or directly into the blocked artery (intra-arterial). The use of […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-121000","post","type-post","status-publish","format-standard","hentry","category-t"],"yoast_head":"\nThrombolytic therapy - Definition of Thrombolytic therapy<\/title>\n<meta name=\"description\" content=\"Administration of a pharmacological agent with the intention of causing thrombolysis of an abnormal blood clot, such as in the coronary (myocardial infarction) or pulmonary (pulmonary embolism) arteries. Available agents include streptokinase, urokinase, tissue plasminogen activator, and APSAC. These preparations may be given either intravenously or directly into the blocked artery (intra-arterial).The use of drugs that degrade blood clots to treat acute myocardial infarction, pulmonary embolism, or stroke.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thrombolytic therapy - Definition of Thrombolytic therapy\" \/>\n<meta property=\"og:description\" content=\"Administration of a pharmacological agent with the intention of causing thrombolysis of an abnormal blood clot, such as in the coronary (myocardial infarction) or pulmonary (pulmonary embolism) arteries. Available agents include streptokinase, urokinase, tissue plasminogen activator, and APSAC. These preparations may be given either intravenously or directly into the blocked artery (intra-arterial).The use of drugs that degrade blood clots to treat acute myocardial infarction, pulmonary embolism, or stroke.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-28T08:20:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-15T10:31:19+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/\",\"name\":\"Thrombolytic therapy - Definition of Thrombolytic therapy\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-07-28T08:20:09+00:00\",\"dateModified\":\"2023-01-15T10:31:19+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Administration of a pharmacological agent with the intention of causing thrombolysis of an abnormal blood clot, such as in the coronary (myocardial infarction) or pulmonary (pulmonary embolism) arteries. Available agents include streptokinase, urokinase, tissue plasminogen activator, and APSAC. These preparations may be given either intravenously or directly into the blocked artery (intra-arterial).The use of drugs that degrade blood clots to treat acute myocardial infarction, pulmonary embolism, or stroke.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thrombolytic therapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Thrombolytic therapy - Definition of Thrombolytic therapy","description":"Administration of a pharmacological agent with the intention of causing thrombolysis of an abnormal blood clot, such as in the coronary (myocardial infarction) or pulmonary (pulmonary embolism) arteries. Available agents include streptokinase, urokinase, tissue plasminogen activator, and APSAC. These preparations may be given either intravenously or directly into the blocked artery (intra-arterial).The use of drugs that degrade blood clots to treat acute myocardial infarction, pulmonary embolism, or stroke.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/","og_locale":"en_US","og_type":"article","og_title":"Thrombolytic therapy - Definition of Thrombolytic therapy","og_description":"Administration of a pharmacological agent with the intention of causing thrombolysis of an abnormal blood clot, such as in the coronary (myocardial infarction) or pulmonary (pulmonary embolism) arteries. Available agents include streptokinase, urokinase, tissue plasminogen activator, and APSAC. These preparations may be given either intravenously or directly into the blocked artery (intra-arterial).The use of drugs that degrade blood clots to treat acute myocardial infarction, pulmonary embolism, or stroke.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/","og_site_name":"Glossary","article_published_time":"2021-07-28T08:20:09+00:00","article_modified_time":"2023-01-15T10:31:19+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/","name":"Thrombolytic therapy - Definition of Thrombolytic therapy","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-07-28T08:20:09+00:00","dateModified":"2023-01-15T10:31:19+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Administration of a pharmacological agent with the intention of causing thrombolysis of an abnormal blood clot, such as in the coronary (myocardial infarction) or pulmonary (pulmonary embolism) arteries. Available agents include streptokinase, urokinase, tissue plasminogen activator, and APSAC. These preparations may be given either intravenously or directly into the blocked artery (intra-arterial).The use of drugs that degrade blood clots to treat acute myocardial infarction, pulmonary embolism, or stroke.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/thrombolytic-therapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Thrombolytic therapy"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/121000","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=121000"}],"version-history":[{"count":2,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/121000\/revisions"}],"predecessor-version":[{"id":204912,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/121000\/revisions\/204912"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=121000"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=121000"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=121000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}